ANTIBE THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.295 CAD | -.--% |
|
-.--% | -68.28% |
| Apr. 24 | Antibe Therapeutics Inc. Announces Board Resignations | CI |
| Apr. 19 | Antibe Therapeutics Seeks Extension of Stay of Proceedings | MT |
Performance
| 3 months | -69.27% | ||
| 6 months | -60.14% | ||
| Current year | -68.28% | ||
| 1 year | -39.80% | ||
| 3 years | -92.77% | ||
| 5 years | -91.81% | ||
| 10 years | -94.64% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Record volume 1
4 317 073
Record volume 2
2 948 911
Record volume 3
2 775 617
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CAD)
15 661 330
Capitalization (USD)
11 493 537
Net sales (CAD)
0
Net sales (USD)
0
Number of employees
11
Sales / Employee (CAD)
0
Sales / Employee (USD)
0
Free-Float
91.46 %
Free-Float capitalization (CAD)
14 323 463
Free-Float capitalization (USD)
10 511 703
Highs and lows
Current year
0.15
1.14
1 year
0.151.23
3 years
0.154.22
5 years
0.158.90
10 years
0.158.90
Indicators
Moving average 20 days
0.37
Moving average 50 days
0.67
Moving average 100 days
0.77
Price spread / (MMA20)
+25.59%
Price spread / (MMA50)
+127.22%
Price spread / (MMA100)
+160.58%
RSI 9 days
39.33
RSI 14 days
35.64
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | -68.28% | -39.80% | 11.49M | ||
| +0.15% | +3.71% | +9.58% | +30.49% | 115B | ||
| +0.51% | +1.06% | +12.41% | +30.07% | 106B | ||
| -1.56% | -2.22% | -2.59% | -13.36% | 21.96B | ||
| +2.05% | -0.27% | -12.38% | -13.17% | 21.87B | ||
| +0.74% | +2.56% | -5.29% | -27.68% | 19.21B | ||
| +0.85% | +7.49% | -3.35% | -25.06% | 18.08B | ||
| -0.45% | -3.23% | -38.57% | -33.48% | 17.71B | ||
| -0.45% | +4.04% | +7.51% | +50.60% | 14.32B | ||
| -0.42% | -0.66% | +35.67% | -12.25% | 12.42B | ||
| +0.60% | +5.72% | -24.50% | -34.85% | 8.23B | ||
| +1.82% | +15.57% | +20.91% | +57.43% | 8.11B | ||
| -0.12% | -0.02% | -0.83% | +29.54% | 7.67B | ||
| -0.14% | -0.71% | -52.57% | -66.69% | 7.49B | ||
| +0.77% | -6.68% | +262.79% | +193.93% | 7.39B | ||
| -0.04% | -8.29% | -3.87% | +33.94% | 6.95B | ||
| Average | +0.20% | +0.42% | +8.54% | +9.98% | ||
| Weighted average by Cap. | +0.27% | +1.90% | +8.35% | +17.02% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -68.28% | ||
| 2023 | +97.87% | ||
| 2022 | -28.79% | ||
| 2021 | -83.21% | ||
| 2020 | -12.67% | ||
| 2019 | +45.16% | ||
| 2018 | +113.79% | ||
| 2017 | -14.71% | ||
| 2016 | -5.56% | ||
| 2015 | -64.00% | ||
| 2014 | -5.66% | ||
| 2013 | -3.64% |
- Stock Market
- Equities
- ATE Stock
- Quotes Antibe Therapeutics Inc.
